learn Tofacitinib
a JAK inhibitor for alopecia areata and other autoimmune conditions
Search
forCommunity Join
3 / 1000+ resultscommunity Xeljanz medication for alopecia universalis?
A person with alopecia universalis is considering using Xeljanz but is advised that Olumiant is more effective for their condition. They are under a dermatologist's care and should expect gradual progress, as follicles dormant for 20 years are challenging to reactivate.
community Anyone with LPP have regrowth with Xeljanz?
The conversation is about using Xeljanz for hair regrowth in individuals with LPP. The user is seeking experiences and expectations from others who have tried this treatment.
community Alopecia Areata Question
A user with alopecia totalis, borderline universalis, seeks advice on getting into a Xeljanz trial or appealing insurance for coverage. They experienced significant hair regrowth but are now seeing hair loss again and want to try Xeljanz.
Research
5 / 155 results
research Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
This study observed that applying JAK-STAT pathway inhibitors to mouse and human skin led to rapid hair growth by inducing the anagen phase of hair follicles.
research Tofacitinib for the treatment of alopecia areata and variants in adolescents
In this retrospective review, tofacitinib treatment was associated with clinically significant hair regrowth in most adolescent patients with alopecia areata, though limitations suggest further studies are needed to confirm these findings.
research Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
This review discusses the role of tyrosine kinase signaling pathways in autoimmune and inflammatory skin diseases and reports no new clinical results, highlighting ongoing research into small-molecule tyrosine kinase inhibitors as potential treatments.
research Tofacitinib for the treatment of lichen planopilaris: A case series
This study found that treatment with oral tofacitinib, alone or with other therapies, was associated with clinical improvement in most patients with recalcitrant lichen planopilaris.
research Efficacy of tofacitinib in treatment of alopecia universalis in two patients
In this study, tofacitinib treatment was associated with significant hair regrowth in two patients with alopecia universalis over eight months, with minimal adverse effects reported.
Experts
— no results
Clinics
— no results